Cargando…

PHorecasting Heritable Pulmonary Arterial Hypertension: Are We Nearly There Yet?

Detalles Bibliográficos
Autor principal:	Aldred, Micheala A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Thoracic Society 2020
Materias:	Editorials
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7706171/ https://www.ncbi.nlm.nih.gov/pubmed/32835509 http://dx.doi.org/10.1164/rccm.202007-2887ED

Ejemplares similares

Food for Thought: The Emerging Role of Intestinal Microbiota in Pulmonary Arterial Hypertension
por: Aldred, Micheala A.
Publicado: (2022)

Regulating the Regulators: Epigenetic Modulation of Regulatory T Cells in Pulmonary Hypertension
por: Farha, Samar, et al.
Publicado: (2023)

DNA Damage and Repair in Pulmonary Arterial Hypertension
por: Sharma, Samantha, et al.
Publicado: (2020)

Stem Cell–derived Nanovesicles for the Treatment of Pulmonary Hypertension: Are We There Yet?
por: Goncharova, Elena A., et al.
Publicado: (2022)

Rationale and design of the PHOspholamban RElated CArdiomyopathy intervention STudy (i-PHORECAST)
por: te Rijdt, W. P., et al.
Publicado: (2021)

Mitochondrial Haplogroups and Risk of Pulmonary Arterial Hypertension
por: Farha, Samar, et al.
Publicado: (2016)

Pulmonary artery endothelium resident endothelial colony-forming cells in pulmonary arterial hypertension
por: Duong, Heng T., et al.
Publicado: (2011)

Genetics and genomics of pulmonary arterial hypertension
por: Morrell, Nicholas W., et al.
Publicado: (2019)

Are we nearly there yet?
por: Battersby, Stephen
Publicado: (2005)

Are we nearly there yet? Starts and stops on the road to use of polygenic scores
por: Moorthie, Sowmiya, et al.
Publicado: (2023)

Are we there yet?
por: McCann, Shaun R.
Publicado: (2022)

Are we anywhere near there yet? The state of harm reduction in North America in 2017
por: Drucker, Ernest, et al.
Publicado: (2017)

Identification of rare sequence variation underlying heritable pulmonary arterial hypertension
por: Gräf, Stefan, et al.
Publicado: (2018)

Regenerative medicine: are we there yet?
por: Badylak, Stephen, et al.
Publicado: (2017)

Precision Oncology: Are We There Yet?
Publicado: (2017)

Hypoxemia in patients with idiopathic or heritable pulmonary arterial hypertension
por: Khirfan, Ghaleb, et al.
Publicado: (2018)

The cascade screening in heritable forms of pulmonary arterial hypertension
por: Varghese, Nidhy P., et al.
Publicado: (2023)

Biomarkers in Alzheimer disease: are we there yet?
por: Generoso, Jaqueline S., et al.
Publicado: (2020)

Value of Information Analysis: Are We There Yet?
por: Tuffaha, Haitham
Publicado: (2020)

Personalized medicine for asthma: Are we there yet?
por: Poon, Audrey H., et al.
Publicado: (2012)

The COVID‐19 world – Are we there yet?
por: Hamamoto, Yoshiyuki
Publicado: (2021)

RASA3 is a candidate gene in sickle cell disease‐associated pulmonary hypertension and pulmonary arterial hypertension
por: Prohaska, Clare C., et al.
Publicado: (2023)

Heritable pulmonary arterial hypertension complicated by multiple pulmonary arteriovenous malformations
por: Arano, Takahiro, et al.
Publicado: (2021)

Capacity building in endometriosis ultrasound: are we there yet?
por: Menakaya, Uche A
Publicado: (2015)

Digital future in perioperative medicine: Are we there yet?
por: Panchagnula, Umakanth, et al.
Publicado: (2019)

Molecular Diagnosis in 100% of Dystrophinopathies: Are We There Yet?
por: Pegoraro, Elena
Publicado: (2021)

Radiofrequency ablation for primary hyperparathyroidism: are we there yet?
por: McManus, Catherine
Publicado: (2023)

Screening for type 1 diabetes: are we nearly there yet?
por: Narendran, Parth
Publicado: (2018)

Estrogen, estrogen receptors, and hepatocellular carcinoma: Are we there yet?
por: Sukocheva, Olga A
Publicado: (2018)

Are we there yet? Pushing the boundaries of endonasal surgery into the brainstem
por: Cohen-Gadol, Aaron A.
Publicado: (2020)

Genomic stability of pulmonary artery endothelial colony-forming cells in culture
por: Drake, Kylie M., et al.
Publicado: (2017)

Drug Therapy for Obstructive Sleep Apnea: Are We There Yet?
por: Schmickl, Christopher N., et al.
Publicado: (2022)

Mortality trends in pulmonary arterial hypertension: Are we just spinning our wheels?
por: Zelt, Jason G. E., et al.
Publicado: (2022)

Bilaterally dilated episcleral vessels in patients with heritable pulmonary arterial hypertension
por: Watanabe, Meri, et al.
Publicado: (2017)

Abandoned embryos in Brazil: advances in the decisions. Are we there yet?
por: de Souza, Maria do Carmo Borges, et al.
Publicado: (2018)

Are We There Yet? Emerging Milestones in Aortic Dissection Care
por: Svensson, Lars G.
Publicado: (2019)

Artificial intelligence as an adjunct tool for breast oncologists – are we there yet?
por: Schlam, I., et al.
Publicado: (2023)

Endothelial Apelin-FGF Link Mediated by MicroRNAs 424 and 503 is Disrupted in Pulmonary Arterial Hypertension
por: Kim, Jongmin, et al.
Publicado: (2012)

Adherence to statin therapy: it seems we know everything, yet we do nothing
por: Banach, Maciej, et al.
Publicado: (2022)

Evidence on technology-driven preoperative exercise interventions: are we there yet?
por: Steffens, Daniel, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_ctftig6rbbvpp2kmrl94f896on